“How do we sell without rebates?”

Pharmaceutical companies are in desperate struggle by withdrawing rebates. Vague boundary of legitimacy is the problem.
(dailypharm)

“We have abandoned rebates. Now we do not know how to do business.”

Sales activity of pharmaceutical companies without illegal rebates, which have been practiced for several decades, is not familiar. Government investigated pharmaceutical companies that are...